msk Flashcards

(52 cards)

1
Q

What are the risk factors for SLE and epidemiology

A

more in women, younger ages (20-40), afrocaribean and asian women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

presentation of SLE

A

(thing flaws) low grade fever, VERY FATIGUED, weight loss
and then system specific symptoms, because SLE is a systemic disease it can affect pretty much any organ so difficult to diagnose!

skin: mouth or other ulcers, butterfly rash or other
joints: small> large joint pain and stiffness
renal: haematuria (and proteinuria but that finding- lupus nephritis)
lungs: breathlessness
brain: depression
heart; pericarditis or myocarditis?
lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SLE pathophysiology

A

autoimmune condition with infiltrates in any system?
HLA, B8 , DR2, DR3 are some immune complexes involved in the infiltration of the organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SLE diagnostics, give one very SENSITIVE and one very SPECIFIC ANTIBODIES

A

sensitive: ANA (99%)
SPECIFIC: anti-ds DNA but only 70% sensitive

other diagnostic indicators
FBC findings:

anaemia
lymphocytopenia
thrombocytopenia due to immune mediated destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GIVE a v specific but very poor sensitivity ab for SLE

A

anti-smith antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

general management of SLE

A

basics are NSAIDS and sun-block
Hydroxychloroquine is the suggested drug
then if specific organs have porblems consider prednisolone and cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

use of ESR and CRP in lupus?

A

ESR is generally used to monitor disease
during active disease the CRP may be normal - a raised CRP may indicate underlying infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

comment on complement and anti ds-DNA levels as a tool to monitor LUPUs

A

complement (C3 and C4 usually low since they are used up in complexes deposited in the organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

polymyalgia rheumatica presentation and demographic

A

large joint pain and stiffness, mainly shoulders and hips
older patients so 60+
usually RAPID ONSET
also kinda FLAWS- low grade fevers, lethargy, appetite loss, weight, sweats, mild polyarthralgia (think case seen on video with retired man thats just feeling sick all the time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

is muscle weakness a feature of polymyalgia rheumatica?

A

noooooo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

polymyalgia rheumatica commonly associated condition

A

giant cell/ temporal arteritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

polymyalgia rheumatica management

A

steroids, patients typically respond dramatically to steroids, failure to do so should prompt consideration of an alternative diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

investigations in polymyalgia rheumatica

A

raised inflammatory markers e.g. ESR > 40 mm/hr
note creatine kinase and EMG normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

myasthenia gravis presentation

A

it is a progressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

myasthenia gravis muscle groups commonly affected and consequent symptom produced

A

extraocular muscles (diplopia)
face muscles (ptosis) ,
neck muscles (dysphagia)
limb griddles - limb weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

associated conditions with myasthenia gravis

A
  • thymoma in 15% of people which is quite high really
  • other autoimmune diseases
  • thymic hyperplasia in 50-70%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

investigations for myasthenia gravis

A
  • single fibre electromyography (high sensitivity)
  • CT thorax to exclude thymoma
  • acetylcholine receptor antibodies present in 85-90% of people
    (of the ones that don’t have these abs 40% have another ab: anti- muscle specific tyrosine kinase abs )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

long term management of myasthenia gravis first line

A
  • long acting acetylcholinesterase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what other treatments may be required for management of myasthenia gravis down the line

A

immunosuppression with prednisolone initially and then maybe azathioprine or some other options

thymectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

myasthenia gravis crisis management

A

plasmapheresis and IV immunoglobulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ankylosing spondylitis presentation

A

Lower back pain and stiffness and sacroiliac pain
Young male in teens or 20s symptom onset> 3 months

24
Q

Pathophysiology of ankylosing spondylitis

A

HLA b27 associated inflammatory condition causing the SACROILIAC joint and vertebral joints most commonly to merge together! Squaring of the vertebra, bamboo spine late presentation ect

25
What makes ankylosing spondylitis stiffness worse and better
Better by movement worse by rest (worse at night and takes at least 30 mins to improve in morning)
26
Key complication of ankylosing spondyllitis and disease lrogression
Vertebral fractures and progression is not linear with flares and remitting stages
27
What other symptoms and associations with ankylosing spondylitis
Weight loss and fatigue Other things associated u get with it ae chest pain anterior uveitis , IBD, RESTRIctive lung disease, anaemia, enthesitis, dactylitis, pulmonary fibrosis in the upper lobes
28
Describe the schober’s test
Make a mark at L5 and one 10 cm above one 5 below . These points are 15 cm apart and when they bend forward this needs to increase by at least 5 in normal person. If not this supports diagnosis of ankylosing spondylitis
29
first line diagnostic investigation of ankylosing spondylitis
pelvic XRAY
30
ankylosing spondylitis investigation if pelvic xray shows no significant findings
MRI
31
ankylosing spondylitis xray findings
osteophytes, squaring of the vertebra syndesmophytes subchondral errosions ossification subchondral sclerosis and fusion of joints
32
first line management of ankylosing spondylitis
1) NSAIDS - ibuprofen and naproxen you can try switching i not wokring 2) steroids during flares 3) next step is targeting TNF so anti-TNF medications like entanercept adalimumab, certolizumab if none of these work there is a new monoclonal antibody against Il 7 CALED secukinumab - new showing promising results
33
other than female gender and age what are some other important risk factors for osteoporosis
low BMI smoking corticosteroid use alcohol family history
34
what is the definition of osteoporosis
low mineral bone density specifically less than 2.5 standard deviations below the young adult mean density (which can be calculated from a DEXA scan)
35
which patients need to be risk assessed for osteoporosis?
all women > 65 and all men >75 younger patients in the presence of risk factors!!!
36
what are causes of SECONDARY osteoporosis
-hypogonadism in either sex including low testosterone in men and premature menopause in women -endocrine conditions, including diabetes mellitus, Cushing's disease, hyperthyroidism -conditions associated with malabsorption, including inflammatory bowel disease, coeliac disease, and chronic pancreatitis. -rheumatoid arthritis and other inflammatory arthropathies.
37
what is the method of risk assessment for osteoporosis
first exclude secondary causes that may need tratment then fragility rusk score such as FRAX or Qfracture
38
based off os the risk score calculations from risk score calculation tools, when should a dexa scan be offered
QFracture if the 10-year fracture risk is ≥ 10% then a DEXA scan should be arranged FRAX a colour 'risk' is given by the calculator - green, orange or red patients in the orange zone should have a DEXA scan if not already done to further refine their 10-year risk patients in the red zone should also have a DEXA scan if not already done to act as a baseline and guide drug treatment
39
when should a DEXA scan be offered without calculating fragility risk score?
> 50 years of age with a history of fragility fracture < 40 years of age who have a major risk factor for fragility fracture - these patients should be referred to a specialist depending on the T-score before starting treatments that may have a rapid adverse effect on bone density (for example, sex hormone deprivation for treatment for breast or prostate cancer)
40
Postmenopausal women, and men age ≥50, who are treated with oral glucocorticoids: if starting ≥7.5 mg/day prednisolone or equivalent for the next 3 months, what to do?
start bone protective treatment at the same time general osteoporosis management as above don't wait for a DEXA scan before starting treatment oral bisphosphonates are used first-line e.g. alendronate or risedronate
41
other than pharmacological management what are the other aspoects of management important in osteoporosis
balanced diet calcium and vitamin d intake and supplementation should be offerred to all unless gp is certain that its fine weight bearing and muscle strengthening secondary causes of osteoporosis should be considered and treated e.g. hypogonadism in women or men e.g. hormone replacement therapy for premature menopause
42
first line pharmacological treatment of osteoporosis and how are they taken
bisphosphonates are the first-line drug treatment for patients at risk of fragility fractures oral bisphosphonates such as alendronate and risedronate are typically first-line. These are often taken weekly are need taking in a particular way to minimise the risk of oesophageal side-effects
43
when is an exception to the rule of bisphosphonates first line and what is given instead
if following hip fracture give IV zolendronate given yearly
44
second line osteoporosis pharmacological management
denosumab
45
what bones in the body does a DEXA SCAN LOOK AT
hips and pelvis
46
most common locations of pathological fractures
wrist (coles fracture), hips, vertebral (presents with kyphosis, decrease in height, painless or painful ect)
47
pathological fracture causes
primary malignancies metastatic malignancies local benign conditions: chronic osteomyelitis, solitary bone cyst bone disease: pagets, osteoporosis, metabolic bone disease, osteogenesis imperfecta
48
osteomalacia causes
vitamin D deficiency ----malabsorption ----lack of sunlight ----diet chronic kidney disease drug induced e.g. anticonvulsants inherited: hypophosphatemic rickets (previously called vitamin D-resistant rickets) liver disease: e.g. cirrhosis coeliac disease
49
presentation of osteomalacia
bone pain bone/muscle tenderness fractures: especially femoral neck proximal myopathy: may lead to a waddling gait
50
investigation for osteomalacia
bloods low vitamin D levels low calcium, phosphate (in around 30%) raised alkaline phosphatase (in 95-100% of patients) x-ray translucent bands (Looser's zones or pseudofractures)
51
treatment of osteomalacia
vitamin D supplmentation ---- a loading dose is often needed initially calcium supplementation if dietary calcium is inadequate
52
Gottron's papules what are they and what condition are they present in
roughened red papules over extensor surfaces of fingers- dermatomyositis